HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Nilüfer Yalçındağ Selected Research
Nilüfer Yalçındağ Research Topics
Disease
1
Uveitis
01/2022
1
Inflammation (Inflammations)
01/2022
1
Disease Progression
01/2022
1
Central Serous Chorioretinopathy
01/2022
1
Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome)
01/2022
1
Tuberculosis (Tuberculoses)
11/2021
1
Choroidal Neovascularization
11/2021
1
Endophthalmitis (Ophthalmia)
01/2020
1
Mycoses (Diseases, Fungus)
01/2020
1
Infections
01/2020
1
Rheumatic Diseases (Rheumatism)
01/2017
1
Vasculitis (Vasculitides)
01/2017
1
Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
01/2017
1
Churg-Strauss Syndrome (Allergic Angiitis)
01/2017
1
Microscopic Polyangiitis
01/2017
1
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
01/2017
1
Optic Neuritis (Retrobulbar Neuritis)
10/2015
Drug/Important Bio-Agent (IBA)
1
Fluorescein (Funduscein)
FDA Link
Generic
01/2022
1
Infliximab (Remicade)
FDA Link
01/2022
1
Coloring Agents (Dyes)
IBA
11/2021
1
Steroids
IBA
01/2020
1
Edetic Acid (EDTA)
FDA Link
01/2017
1
Methotrexate (Mexate)
FDA Link
Generic
01/2017
1
Mycophenolic Acid (Cellcept)
FDA Link
Generic
01/2017
1
Rituximab (Mabthera)
FDA Link
01/2017
1
Antineutrophil Cytoplasmic Antibodies (ANCA)
IBA
01/2017
1
Prednisolone (Predate)
FDA Link
Generic
10/2015
Therapy/Procedure
2
Therapeutics
01/2022 - 11/2021
1
Aftercare (After-Treatment)
01/2022
1
Photochemotherapy (Photodynamic Therapy)
01/2022
1
Intravitreal Injections
01/2020
1
Remission Induction
01/2017
1
Plasma Exchange
10/2015